The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

bioprocessors.com

Founded Year

2000

Stage

Acquired | Acquired

Total Raised

$56.02M

About BioProcessors Corporation

BioProcessors is a company that is developing an automated, parallel, miniaturized platform to enable the growth, culture, study and analysis of living cells.

BioProcessors Corporation Headquarter Location

12 Cabot Road

Woburn, Massachusetts, 01801,

United States

781-935-1400

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

BioProcessors Corporation Patents

BioProcessors Corporation has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/7/2004

12/15/2009

Cell culture, Biotechnology, Cell biology, Startup accelerators, Gas sensors

Grant

Application Date

6/7/2004

Grant Date

12/15/2009

Title

Related Topics

Cell culture, Biotechnology, Cell biology, Startup accelerators, Gas sensors

Status

Grant

Latest BioProcessors Corporation News

Working to Improve the Efficiency of Bioprocessing

Sep 28, 2021

Source: Corning Bioprocessors always look for ways to make more product in less floorspace and at a lower cost. “A major challenge in manufacturing adherent cells for advanced therapies is producing the large quantities of cells needed in a cost-effective manner,” says Tara St. Amand, PhD, director of business technology, bioprocess, at Corning. “Space constraints often hinder large-scale bioproduction, and labor-intensive processes add time and cost to mid-to-large scale biotherapeutic production.” St. Amand points out that advances in production are really needed with gene therapies based on recombinant adeno-associated viral and lentiviral vectors. “With the rapidly growing number of clinical trials underway and planned, the industry needs scalable, cost-efficient systems for manufacturing cells and cell products, such as viral vectors,” she says. Tara St. Amand, PhD, serves as director of business technology, bioprocess, at Corning. In August at the 2021 Bioprocessing Summit in Boston, Corning introduced its Ascent Fixed Bed Reactor system. St. Amand describes this system as “an adherent cell-culture platform designed to deliver significant surface area intensification and high-yield bioproduction cost efficiently.” When asked what key technological improvements make this platform different, St. Amand highlights the bioreactor design. “It features a specially treated and packed woven polymer mesh substrate that is designed to provide uniform fluid dynamics, even media and cell distribution, and efficient waste media removal,” she explains. “Depending on the desired application, preliminary test data show transfection efficiencies greater than 90% and cell harvests with yields and viability greater than 90%.” In some cases, bioprocessors also need a platform that could run in most any lab. The Corning system can be used without a biosafety cabinet or cleanroom. “Aseptic connectors allow the user to remove the bioreactor vessel for sampling inside a laminar flow hood without interrupting a run,” according to St. Amand. In the future, Corning plans to scale up this platform—reaching volumes as high as 1,000 square meters. “The linear scalability of the platform, combined with the viable cell harvest capability, is designed to enable each bioreactor to serve as a seed train for the larger bioreactors,” notes St. Amand. Even more lies ahead, because she states that while the initial focus is on viral-vector production, the Ascent platform will also support “other advanced therapy workflows that require the harvest of significant volumes of cells, such as regenerative medicine.” Share

  • When was BioProcessors Corporation founded?

    BioProcessors Corporation was founded in 2000.

  • Where is BioProcessors Corporation's headquarters?

    BioProcessors Corporation's headquarters is located at 12 Cabot Road, Woburn.

  • What is BioProcessors Corporation's latest funding round?

    BioProcessors Corporation's latest funding round is Acquired.

  • How much did BioProcessors Corporation raise?

    BioProcessors Corporation raised a total of $56.02M.

  • Who are the investors of BioProcessors Corporation?

    Investors of BioProcessors Corporation include Seahorse Bioscience, Oxford Bioscience Partners, HLM Venture Partners, New Science Ventures, Life Sciences Partners and 6 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.